Switch to:
More From Other Websites
Stocks That Fell to 3-Year Lows in the Week of May 19 May 21 2017
Amgen, Gilead, Biogen Won't Lead The Biotech Boom — So Who Will? May 19 2017
5 Reasons Big Biotech Could Gain 25%-30% May 19 2017
Why Stay Bullish On Gilead May 19 2017
For millions of Chinese with rare diseases, some relief in sight May 18 2017
Cramer's lightning round: It's OK to own this stock — as long as you're diversified May 18 2017
Glancy Prongay & Murray LLP Commences Investigation on Behalf of Alexion Pharmaceuticals, Inc.... May 18 2017
Alexion's (ALXN) Strensiq Results Positive in Long-Term Study May 17 2017
Here's Why Omeros Corporation Is Surging Again Today May 17 2017
Moderna Can't Escape My Intellectual Property, Says Arbutus CEO May 16 2017
3 Top Healthcare Stocks to Buy Now May 16 2017
Rady Children’s Institute for Genomic Medicine and Alexion Pharmaceuticals Partner to Speed the... May 16 2017
Long-term Data Confirm Benefits of Treatment with Strensiq® (asfotase alfa) in Adolescents and... May 15 2017
ALXN1210 Is Expected to Boost Alexion Pharmaceuticals’ Revenue May 11 2017
Alexion Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : ALXN-US : May... May 11 2017
Alexion Pharmaceuticals Has Raised Its 2017 Earnings Guidance May 11 2017
Alexion Global Headquarters Earns Highest LEED® Green Building Certification May 11 2017
New Patient Starts Expected to Drive Soliris’s Revenue in 2017 May 10 2017
Alexion Pharmaceuticals Projects Robust 2017 Revenue Performance May 10 2017
Analysts’ Latest Recommendations for Alexion and Its Peers May 10 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

FEEDBACK